Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Samsung
MedTech
Samsung backs Alzheimer's blood test developer C2N Diagnostics
Samsung backed the Alzheimer’s disease blood test developer C2N Diagnostics, with $10 million to help scale up its commercial work and R&D pipeline.
Conor Hale
Mar 13, 2025 12:15pm
FDA warns against wearables touting noninvasive glucose sensors
Feb 23, 2024 11:57am
Samsung scores FDA OK for smartwatch sleep apnea feature
Feb 12, 2024 11:49am
Samsung taps Lunit to bring AI detection to its X-ray scanners
Jan 29, 2024 10:23am
Samsung plots noninvasive glucose sensor devices: Bloomberg
Jan 23, 2024 12:45pm
JPM24: Flagship unveils life sci tech-focused initiative
Jan 9, 2024 12:58pm
